isradipine has been researched along with Autoimmune Diseases in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillen, C | 1 |
| Prieto, A | 1 |
| Alvarez De Buergo, M | 1 |
| Villa, L | 1 |
| Rico, H | 1 |
| Zea, A | 1 |
| Hernandez, MP | 1 |
| Alvarez-Mon, M | 1 |
1 other study available for isradipine and Autoimmune Diseases
| Article | Year |
|---|---|
Isradipine, a calcium-channel antagonist, has immunosuppressor activity on T lymphocytes from peripheral blood and synovial fluid from patients with autoimmune arthritis.
Topics: Arthritis; Autoimmune Diseases; Calcium Channel Blockers; Female; Humans; Immunosuppressive Agents; | 1995 |